About Us
Kim Norman
Sr. Director, Finance
Kim has more than 12 years of business experience within the life sciences sector. Prior to joining Tarsus, she was Director, Corporate Finance and Accounting at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) where she was responsible for their financial planning & analysis, accounting operations, Board and SEC reporting, and various IT system implementations to enhance finance and accounting capabilities.
Prior to joining Spectrum in 2013, Kim served as FP&A Manager with Endologix, Inc. (NASDAQ: ELGX), a medical device company that specializes in stent grafts and accompanying delivery systems for the treatment of abdominal aortic aneurysms.
Kim began her career in public accounting with PriceWaterhouseCoopersLLP. She earned her B.S. in Accounting from University of Arizona in Tucson, Arizona and is a Certified Public Accountant (license active in California).